Innate immunity in heart transplantation

Current Opinion in Organ Transplantation

Volumn 14, Issue 5, 2009, Pages 571-576

  Millington, Timothy M ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Complement; Heart transplant; Innate immunity; Natural killer cells; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR;

ACUTE GRAFT REJECTION; CARDIAC GRAFT REJECTION; COMPLEMENT DEPOSITION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; REPERFUSION INJURY; REVIEW;

GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; PROGNOSIS;

EID: 73349103424     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832e7158     Document Type: Review

References (34)

1. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008; 117:2131-2141. This review summarizes new insights into the pathogenesis, detection and treatment of CAV.
2. Gaudin P, Rayburn B, Hutchins G, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994; 18:338-346.
3. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in theheart. Am J Physiol Heart Circ Physiol 2009;296:H1-H12. This is an excellent in-depth article on TLRs and their influence on the heart.
4. Ramachandran S, Goers T, Liu W, et al. 329: TLR2 signaling blocks regulatory T cell suppression leading to immune activation following cardiac allotransplantation. J Heart Lung Transplant 2006; 25:S157-S1157.
5. Karikó K, Ni H, Capodici J, et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279:12542-12550.
6. Hardarson H, Baker J, Yang Z, et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ Physiol 2007; 292:H251-H258.
7. Porrett P, Yuan X, LaRosa D, et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008; 181:1692-1699. This study demonstrates that TLR activation interferes with tolerance to cardiac allografts by modulating the suppressive activity of Tregs.
8. Shirali A, Goldstein D. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transplant 2008; 13:20-25.
9. Zou N, Ao L, Cleveland J, et al. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008; 294:H2805-H2813. This study provides evidence that ischemia/reperfusion leads to endogenous signaling that, in TLR-dependent fashion, creates an inflammatory milieu.
10. Andrassy M, Volz H, Igwe JC, et al. High-mobility group box-1 in ischemiareperfusion injury of the heart. Circulation 2008; 117:3216-3226.
11. Cha J, Wang Z, Ao L, et al. Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 2008; 85:1678-1685. A study demonstrating that the cytokine release caused by TLR4 has immediate effects on the function of reperfused myocardium.
12. Yang J, Yang J, Ding J, et al. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 2008; 31:304-312.
13. Kaczorowski D, Nakao A, Mollen K, et al. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 2007; 84:1279-1287.
14. Methe H, Zimmer E, Grimm C, et al. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78:1324-1331.
15. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6:2282-2291.
16. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457:557-561. This paper describes one of two recent studies demonstrating the ability of NK cells to acquire a memory phenotype.
17. Cooper M, Elliott J, Keyel P, et al. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 2009; 106:1915-1919. This paper describes the second recent study demonstrating the ability of NK cells to acquire a memory phenotype.
18. Kroemer A, Xiao X, Degauque N, et al. The Innate NK Cells, Allograft Rejection, and a Key Role for IL-15. J Immunol 2008; 180:7818-7826. In this experiment, it was shown that NK cells are capable of rejecting a skin transplant in a recipient that lacks an adaptive immune system.
19. Szot G, Zhou P, Rulifson I, et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1: 38-46.
20. McNerney M, Lee K, Zhou P, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6:505-513.
21. Kim J, Chang C, Hayden T, et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179:6416-6420.
22. Chen D, Weber M, Lechler R, et al. NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model. Xenotransplantation 2006; 13:408-414.
23. Fildes J, Bishop P, Mitchell J, et al. 422: natural killer cells deplete from peripheral blood and increase in myocardial tissue during acute rejection following heart transplantation. J Heart Lung Transplant 2008; 27:S212-S213.
24. Fildes J, Yonan N, Tunstall K, et al. Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation. J Heart Lung Transplant 2008; 27:203-207. A report that NK cells migrate from peripheral blood to the lung during pulmonary allograft rejection. There is preliminary evidence in [23] that a similar process occurs in cardiac allografts.
25. Uehara S, Chase C, Kitchens W, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175:3424-3430.
26. Hamerman J, Ogasawara K, Lanier L. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004; 172:2001-2005.
27. Kloss M, Decker P, Baltz K, et al. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol 2008; 181:6711-6719.
28. Hochweller K, Striegler J, Hämmerling G, Garbi N. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur J Immunol 2008; 38: 2776-2783.
29. Baldwin W, Samaniego-Picota M, Kasper E, et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 1999; 68:894-900.
30. Poelzl G, Ullrich R, Huber A, et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 2005; 18:313-317.
31. Keslar K, Rodriguez E, Tan C, et al. Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 2008; 86:1319-1321.
32. Pavlov V, Raedler H, Yuan S, Leisman S, et al. Donor deficiency of decayaccelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol 2008; 181:4580-4589.
33. Ferraresso M, Macor P, Valente M, et al. Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. Transplantation 2008; 86:1445-1451. Here, it is demonstrated that interference with complement deposition can ameliorate the inflammatory response and the cellular injury associated with ischemia/reperfusion.
34. Fildes J, Shaw S, Walker A, et al. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation. J Heart Lung Transplant 2008; 27:1353-1356.